Ask Warren

Daesung Microbiological Labs

036480 · KOSDAQ · ₩036480 · 대성미생물

₩5,490▼ ₩30 (0.54%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩6B₩5.1B₩6.9B₩7.2B₩6.7B₩5.2B₩6.8B₩5.8B
Cost of sales₩5.3B₩4.1B₩5.5B₩5.3B₩4.6B₩4.1B₩4.4B₩5.4B
Gross profit₩707M₩987M₩1.4B₩1.9B₩2.1B₩1.1B₩2.4B₩412M
Operating income−₩472M−₩516M−₩270M₩591M₩728M−₩334M₩729M−₩941M
Net income₩0−₩208M₩243M₩753M−₩134M−₩264M₩988M−₩1.3B
Net income to shareholders₩0−₩208M₩243M₩753M−₩134M−₩264M₩988M−₩1.3B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩57B₩57B₩58B₩58B₩58B₩58B₩58B₩60B
Current assets₩25B₩25B₩25B₩25B₩25B₩23B₩24B₩25B
Cash and equivalents₩2.8B₩3.3B₩3.4B₩3.8B₩4.9B₩4.7B₩3.6B₩4.1B
Total liabilities₩23B₩22B₩23B₩23B₩24B₩23B₩23B₩26B
Current liabilities₩7.3B₩8.4B₩8.5B₩8.7B₩7.7B₩4.9B₩4.5B₩6.9B
Borrowings₩16B₩15B₩15B₩15B₩17B₩20B₩19B₩21B
Total equity₩34B₩35B₩35B₩35B₩34B₩35B₩35B₩34B
Shareholders' equity₩34B₩35B₩35B₩35B₩34B₩35B₩35B₩34B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩335M₩292M₩972M−₩624M₩1.1B−₩82M₩1.3B₩450M
Free cash flow₩335M₩292M₩972M−₩624M₩1.1B−₩82M₩1.3B₩450M

Consolidated where available. Amounts in won.

Also known as: Daesung Microbiological Labs / 대성미생물 / 036480 / KRX:036480

Source: KRX statistical information